On the other hand, BIRC5 overexpression is related to adverse outcome in breast, lung, colorectal, prostate, and ovarian cancer and is thought to be a promising cancer diagnostic biomarker (Duffy et al., 2007; Fawzy et al., 2012). The gene discussed is BIRC5; the disease is ovarian carcinoma.